TREAT-COVID: addressing critical issues and TheRapeutics Emerging in TrAnsplantaTion in COVID-19
The pandemic continues to be hard for many transplant recipients and their families and caregivers. COVID-19 vaccines are less effective for transplant recipients. This is due to their suppressed immune systems. As a result, transplant recipients who get COVID-19 are at a higher risk of hospitalization and death. Preventing severe disease in transplant recipients requires different strategies.
A New Study
The CDTRP’s COVID-19 research is centered on addressing patient, family, and caregiver priorities. We have engaged the transplant community to learn how research and policy can support the recovery of quality of life during COVID-19 and in future health concerns.
We are currently recruiting from 10 out of the 11 sites, see details below:
Alberta – University of Alberta, Stollery Children’s Hospital
Québec – Centre Hospitalier Universitaire de Quebec (CHUQ), Centre Hospitalier Universitaire de Montréal (CHUM), Montreal Children’s Hospital and Institut de Cardiologie de Montréal (ICM)
Ontario – London Health Sciences Center, UHN
British Columbia – BC Children’s Hospital, Vancouver General Hospital
Recruitment from the final site will begin soon.
Learn more here: https://cdtrp.ca/en/treatcovid/
Enroll here: https://omc.ohri.ca/TREATCovid/Default.aspx
